Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes. | Front Cardiovasc Med | 2022 | 35686037 | PubTator, text mining | PubMed |
| Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. | Comput Struct Biotechnol J | 2022 | 35685361 | PubTator, text mining | PubMed |
| Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19? | Int J Mol Sci | 2022 | 35682950 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Maps of Lower-Grade Gliomas. | Cancers (Basel) | 2022 | 35681780 | PubTator, text mining | PubMed |
| Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35681561 | PubTator, text mining | PubMed |
| Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET. | Nat Commun | 2022 | 35676290 | PubTator, text mining | PubMed |
| The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. | Theranostics | 2022 | 35664076 | PubTator, text mining | PubMed |
| Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. | Front Immunol | 2022 | 35663932 | PubTator, text mining | PubMed |
| Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types. | Genome Biol | 2022 | 35659055 | PubTator, text mining | PubMed |
| Establishment and Verification of a Gene Signature for Diagnosing Type 2 Diabetics by WGCNA, LASSO Analysis, and In Vitro Experiments. | Biomed Res Int | 2022 | 35655479 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients. | PLoS One | 2022 | 35639708 | PubTator, text mining | PubMed |
| The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b. | mBio | 2022 | 35638730 | PubTator, text mining | PubMed |
| Integrin α10 regulates adhesion, migration, and osteogenic differentiation of alveolar bone marrow mesenchymal stem cells in type 2 diabetic patients who underwent dental implant surgery. | Bioengineered | 2022 | 35635091 | PubTator, text mining | PubMed |
| The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro. | iScience | 2022 | 35634575 | PubTator, text mining | PubMed |
| Antiviral Activities of Interleukin-27: A Partner for Interferons? | Front Immunol | 2022 | 35634328 | PubTator, text mining | PubMed |
| Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease. | Viruses | 2022 | 35632812 | PubTator, text mining | PubMed |
| Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response. | Viruses | 2022 | 35632732 | PubTator, text mining | PubMed |
| Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3. | Viruses | 2022 | 35632606 | PubTator, text mining | PubMed |
| The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2. | Pathogens | 2022 | 35631059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=29